Webchat With Dr. Matulonis: The Latest in Ovarian Cancer Treatment

Information From an Expert

Each year in the United States, more than 22,000 women are diagnosed with ovarian cancer. Understanding new treatments, as well as how and when to access innovative options available through clinical trials, is important in order to achieve the best outcomes.

Ursula Matulonis, MD, is the medical director of the Gynecologic Oncology Program at Dana-Farber Brigham Cancer Center, and one of the leaders of the Institute's Susan F. Smith Center for Women's Cancers.

Dr. Matulonis' research focuses on new treatments for gynecologic malignancies, with a particular emphasis on ovarian cancer. She is the principal investigator for several ovarian cancer clinical trials and serves on the National Comprehensive Cancer Network’s ovarian cancer committee, which sets patient care guidelines for physicians across the country. Dr. Matulonis has received several awards for her dedication and excellence in the field.